Genetics in Hematological Malignancies
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 10 November 2025 | Viewed by 390
Special Issue Editor
Interests: MDS; leukemia; acute myeloid leukemia; acute lymphoblastic leukemia; non-Hodgkin lymphoma; neuroblastoma; microarrays; NGS; cytogenetics; targeted therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hematological malignancies, including leukemias, lymphomas, and myelomas, are characterized by complex genetic alterations that drive their pathogenesis. This Special Issue aims to explore the role of genetics in understanding these diseases, focusing on recent advancements in genomic technologies and their application in clinical practice. Topics may include the discovery of novel genetic mutations, the impact of epigenetics on disease progression, and the importance of genetic profiling for personalized treatment strategies. Additionally, the Special Issue will highlight the significance of next-generation sequencing and bioinformatics in identifying biomarkers for diagnosis and prognosis. By fostering a deeper understanding of the genetic landscape of hematological malignancies, it seeks to contribute to the development of innovative therapeutic approaches and improve patient outcomes.
Dr. Monika Lejman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematological malignancies
- genomic alterations
- personalized medicine
- next-generation sequencing
- epigenetics
- biomarkers
- leukemia
- lymphoma
- myeloma
- genetic profiling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
